A. Nosari, A. Tedeschi, F. Ricci and M. Montillo (2008) “Characteristics and stage of the underlying diseases could determine the risk of opportunistic infections in patients receiving alemtuzumab”, Haematologica. Pavia, Italy, 93(2), pp. e30-e31. doi: 10.3324/haematol.12465.